Effect of ω-3 fatty acid supplementation on plasma phospholipid fatty acid composition.
| Baseline | ω-3 | Placebo | p Value | |
|---|---|---|---|---|
| EPA | 2.0±0.2 | 3.7±0.4 | 1.7±0.1 | p<0.0001 |
| DHA | 4.8±0.3 | 5.6±0.2 | 4.4±0.3 | p<0.0001 |
| α-Linolenic acid | 0.3±0.01 | 0.3±0.02 | 0.3±0.03 | 0.3 |
| Arachidonic acid | 12.5±0.4 | 11.0±0.3 | 11.6±0.5 | 0.0005 |
| Linoleic acid | 18.8±0.6 | 19.0±0.6 | 20.0±0.6 | 0.1 |
| Palmitic acid | 28.2±0.4 | 27.9±0.3 | 28.2±0.3 | 0.6 |
| Stearic acid | 13.8±0.3 | 14.1±0.2 | 13.9±0.2 | 0.4 |
| Oleic acid | 13.3±0.5 | 13.0±0.4 | 13.8±0.5 | 0.1 |
Mean±SEM. Data analysed using one-way ANOVA. p Values in the table are for the difference between the three means. p Values for individual comparisons are below.
EPA: baseline versus ω-3, p<0.0001; baseline versus placebo, p=NS; ω-3 versus placebo, p<0.0001.
DHA: baseline versus ω-3, p<0.01; baseline versus placebo, p=NS; ω-3 versus placebo, p<0.0001.
Arachidonic acid: baseline versus ω-3, p<0.001; baseline versus placebo, p=0.05; ω-3 versus placebo, p=NS.
EPA, Eicosapentaenoic acid; DHA, Docosahexaenoic acid.